NovaBay Pharmaceuticals, Inc.
USD1.47
-0.48 (-24.62%)
CEO
Michael Kazley
IPO Date
2007-10-26
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.47
Prev. Close
$1.95
Day Low
$1.47
Day High
$1.47
52W Low
$1.11
52W High
$99.75
Market Cap
$0.04B
Volume
0.09M
| -0.1 |
| 31 Dec 2023 | FY | 58.2% | -58.8% | -185.4% | -12.2% | 0.79 | 1.67 | -0.0 |
| 31 Dec 2022 | FY | 54.0% | -73.6% | -100.5% | -64.7% | 0.19 | 2.66 | -0.0 |
| 31 Dec 2021 | FY | 63.8% | -57.1% | -57.3% | -24.3% | 0.05 | 3.83 | -0.0 |
| 31 Dec 2020 | FY | 60.0% | -111.1% | -89.6% | -22.9% | 0.04 | 5.03 | -0.0 |
| 31 Dec 2019 | FY | 73.7% | -146.4% | -992.6% | -86.1% | 4.16 | 1.65 | -0.0 |
| 31 Dec 2018 | FY | 88.0% | -52.3% | -132.1% | -69.9% | 0.00 | 2.24 | -0.0 |
| 31 Dec 2017 | FY | 84.7% | -40.6% | -285.4% | -73.4% | 0.00 | 1.81 | -0.0 |
| 31 Dec 2016 | FY | 79.3% | -110.5% | -185.2% | -85.5% | 0.00 | 3.35 | -0.0 |
| -0.1 |
| 30 Sept 2025 | Q3 | 8.1% | -248.2% | -79.1% | -37.1% | 0.59 | 1.98 | -0.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -45.3% | -27.8% | 0.25 | 2.85 | -0.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -57.2% | -35.8% | 0.18 | 2.95 | -0.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 939.5% | -2.6% | -12.96 | 0.68 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -113.1% | -31.3% | 1.18 | 1.15 | -0.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 256.9% | -40.4% | -3.26 | 0.62 | -0.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -2008.7% | -60.0% | 15.14 | 0.92 | -0.0 |
| 31 Dec 2023 | Q4 | 51.5% | -81.8% | -51.9% | -3.4% | 0.79 | 1.67 | -0.0 |